✦ LIBER ✦

Erratum: Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

✍ Scribed by Rother, Russell P; Rollins, Scott A; Mojcik, Christopher F; Brodsky, Robert A; Bell, Leonard

Book ID: 109909570
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 57 KB
Volume: 25
Category: Article
ISSN: 1087-0156
DOI: 10.1038/nbt1207-1488c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery and development of the complem

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

✍ Rother, Russell P; Rollins, Scott A; Mojcik, Christopher F; Brodsky, Robert A; B 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 680 KB

Treatment of paroxysmal nocturnal hemogl

Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab

✍ Alexander Röth; Ulrich Dührsen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

Long-term effect of the complement inhib

Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria

✍ Peter Hillmen; Modupe Elebute; Richard Kelly; Alvaro Urbano-Ispizua; Anita Hill; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

## Abstract Paroxysmal nocturnal hemoglobinuria (PNH) is a debilitating and life‐threatening disease in which lysis of PNH red blood cells frequently manifests with chronic hemolysis, anemia, and thrombosis. Renal damage in PNH is associated with chronic hemosiderosis and/or microvascular thrombosi

Paroxysmal nocturnal hemoglobinuria (PNH

Paroxysmal nocturnal hemoglobinuria (PNH) and pregnancy in the era of eculizumab

✍ Alexey V. Danilov; Hedy Smith; Sabrina Craigo; Dianne M. Feeney; Valerie Relias; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Safety and efficacy of the terminal comp

Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial

✍ Yuzuru Kanakura; Kazuma Ohyashiki; Tsutomu Shichishima; Shinichiro Okamoto; Kiyo 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 307 KB

Protease inhibitors and haptoglobin for

Protease inhibitors and haptoglobin for treatment of renal failure in paroxysmal nocturnal hemoglobinuria

✍ Hattori, Koichi; Hirano, Takao; Oshimi, Kazuo 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

## Disseminated Histoplasmosis Following Prolonged Low-Dose Methotrexate Therapy To the Editor: A 43-year-old woman from central Minnesota presented to her primary internist with a 4-month history of weight loss and abdominal distension and a 2-week history of fevers, sweats, weakness, and anorexia